Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin + Procarbazine vs Procarbazine in Recurrent Glioma
NCT00003564Phase 3Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of isotretinoin in malignant glioma (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Time to Progression and Overall Survival. Status: withdrawn.
02
Drugs
isotretinoin
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00003564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003564.